— Know what they know.
Not Investment Advice

PDEX NASDAQ

Pro-Dex, Inc.
1W: -10.7% 1M: +2.4% 3M: +3.6% YTD: +69.9% 1Y: +89.6% 3Y: +300.4% 5Y: +146.4%
$64.07
-1.29 (-1.97%)
 
Weekly Expected Move ±13.7%
$47 $55 $64 $73 $82
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 53 · $204.6M mcap · 2M float · 4.60% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.2 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 17.5%  ·  5Y Avg: 15.0%
Cost Advantage ★
74
Intangibles
47
Switching Cost
50
Network Effect
44
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PDEX shows a Weak competitive edge (53.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 17.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PDEX receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-09-04 B+ A-
2026-08-14 A- B+
2026-07-01 B+ A-
2026-05-18 A- B+
2026-05-04 B+ A-
2026-05-01 A- B+
2026-04-27 B+ A-
2026-04-21 A- B+
2026-02-02 A A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 64 Grade A
Profitability
72
Balance Sheet
86
Earnings Quality
36
Growth
72
Value
59
Momentum
72
Safety
100
Cash Flow
45
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PDEX scores highest in Safety (100/100) and lowest in Earnings Quality (36/100). An overall grade of A places PDEX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
7.74
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-2.06
Unlikely Manipulator
Ohlson O-Score
-8.31
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 95.7/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.53x
Accruals: 9.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PDEX scores 7.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PDEX scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PDEX's score of -2.06 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PDEX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PDEX receives an estimated rating of AAA (score: 95.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PDEX's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.18x
PEG
0.29x
P/S
2.64x
P/B
4.34x
P/FCF
28.18x
P/OCF
26.82x
EV/EBITDA
10.17x
EV/Revenue
2.62x
EV/EBIT
10.94x
EV/FCF
29.45x
Earnings Yield
7.03%
FCF Yield
3.55%
Shareholder Yield
1.79%
Graham Number
$36.48
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.2x earnings, PDEX trades at a reasonable valuation. An earnings yield of 7.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $36.48 per share, 76% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.758
NI / EBT
×
Interest Burden
0.971
EBT / EBIT
×
EBIT Margin
0.239
EBIT / Rev
×
Asset Turnover
1.143
Rev / Assets
×
Equity Multiplier
1.610
Assets / Equity
=
ROE
32.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PDEX's ROE of 32.4% is driven by Asset Turnover (1.143), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$158.57
Price/Value
0.37x
Margin of Safety
63.08%
Premium
-63.08%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PDEX's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PDEX actually compounded EPS at 26.3% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. PDEX trades at a -63% premium to its adjusted intrinsic value of $158.57, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 15.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$64.07
Median 1Y
$66.44
5th Pctile
$24.61
95th Pctile
$178.89
Ann. Volatility
61.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Financial
ancial Officer
$— $— $12,879

CEO Pay Ratio

11:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $441,303
Avg Employee Cost (SGA/emp): $38,830
Employees: 206

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
206
+13.8% YoY
Revenue / Employee
$376,447
Rev: $77,548,000
Profit / Employee
$66,320
NI: $13,662,000
SGA / Employee
$38,830
Avg labor cost proxy
R&D / Employee
$16,238
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 20.5% 22.1% 15.5% 15.2% 16.9% 16.4% 20.7% 25.9% 20.5% 18.9% 15.3% 6.8% 16.8% 21.2% 28.3% 26.6% 30.9% 30.9% 29.8% 32.4% 32.43%
ROA 11.7% 12.0% 7.7% 7.9% 8.6% 8.5% 11.0% 14.6% 11.7% 10.7% 8.9% 4.1% 10.0% 12.1% 16.3% 15.8% 18.9% 18.5% 17.2% 20.1% 20.14%
ROIC 12.1% 14.1% 11.5% 10.5% 11.0% 9.5% 12.0% 10.3% 11.9% 12.4% 13.1% 15.4% 17.1% 17.6% 19.7% 17.3% 18.0% 18.8% 14.8% 17.5% 17.47%
ROCE 16.5% 18.4% 13.0% 13.7% 14.1% 14.1% 16.9% 14.8% 10.0% 8.6% 6.8% 8.1% 17.1% 21.7% 27.5% 27.7% 31.2% 32.2% 28.8% 30.2% 30.17%
Gross Margin 34.3% 33.5% 30.8% 27.3% 26.7% 23.2% 29.1% 31.6% 30.6% 22.3% 28.0% 27.2% 34.6% 30.2% 33.3% 19.9% 29.0% 30.8% 30.7% 34.7% 34.75%
Operating Margin 13.2% 15.7% 11.0% 9.4% 8.6% 10.1% 15.8% 15.1% 15.4% 6.2% 15.5% 15.6% 20.2% 16.0% 20.9% 7.7% 16.8% 17.5% 15.5% 17.3% 17.30%
Net Margin 10.7% 9.1% 5.0% 11.1% 9.7% 7.8% 12.4% 35.8% -5.2% 4.0% 4.6% 10.6% 16.6% 12.1% 18.8% 6.8% 25.3% 11.7% 19.7% 14.0% 14.00%
EBITDA Margin 16.8% 14.9% 10.0% 14.2% 14.6% 13.2% 16.1% 17.6% -3.5% 8.3% 9.4% 15.9% 25.3% 18.5% 20.9% 20.6% 36.3% 18.1% 29.6% 19.3% 19.29%
FCF Margin -19.2% -3.7% 7.5% -6.0% -3.8% -8.7% -3.4% 10.7% 7.8% 9.6% 13.0% 11.9% 11.3% 2.7% -2.7% -4.4% -3.1% 8.4% 9.3% 8.9% 8.89%
OCF Margin 3.8% 2.6% 13.3% -2.0% -1.5% -5.8% -0.9% 12.7% 10.3% 12.3% 15.6% 14.3% 13.5% 4.6% -0.8% -2.5% -1.8% 9.0% 9.8% 9.3% 9.34%
ROE 3Y Avg snapshot only 20.03%
ROE 5Y Avg snapshot only 19.72%
ROA 3Y Avg snapshot only 12.35%
ROIC 3Y Avg snapshot only 12.43%
ROIC Economic snapshot only 15.35%
Cash ROA snapshot only 9.72%
Cash ROIC snapshot only 12.84%
CROIC snapshot only 12.22%
NOPAT Margin snapshot only 12.70%
Pretax Margin snapshot only 23.23%
R&D / Revenue snapshot only 4.31%
SGA / Revenue snapshot only 10.31%
SBC / Revenue snapshot only 0.89%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 22.82 18.08 18.76 15.43 16.93 15.19 11.95 9.35 9.79 11.92 14.27 32.07 18.87 23.12 17.66 16.29 10.10 11.21 13.38 14.22 15.182
P/S Ratio 2.46 2.12 1.59 1.42 1.52 1.31 1.24 1.50 1.19 1.31 1.25 1.27 1.73 2.56 2.58 2.20 1.61 1.76 2.15 2.50 2.638
P/B Ratio 4.53 3.97 2.78 2.34 2.68 2.37 2.30 2.18 1.79 1.99 2.00 2.21 3.18 4.90 4.69 3.99 2.72 3.05 3.55 4.08 4.339
P/FCF -12.82 -57.22 21.14 -23.64 -39.80 -15.16 -36.36 14.00 15.18 13.61 9.68 10.65 15.34 95.31 -94.60 -49.94 -52.03 21.11 23.05 28.18 28.180
P/OCF 64.17 82.80 12.02 — — — — 11.78 11.48 10.63 8.06 8.87 12.77 55.05 — — — 19.67 21.87 26.82 26.818
EV/EBITDA 15.92 12.89 12.93 12.51 13.19 12.21 10.04 11.24 13.08 15.12 17.53 17.22 12.30 15.95 13.58 11.02 6.80 7.49 8.65 10.17 10.171
EV/Revenue 2.67 2.31 1.81 1.76 1.79 1.61 1.46 1.73 1.41 1.44 1.36 1.39 1.85 2.77 2.73 2.34 1.66 1.81 2.28 2.62 2.617
EV/EBIT 17.91 14.33 14.96 14.29 15.09 14.00 11.28 12.78 16.07 19.51 24.69 23.46 14.27 18.01 13.85 12.08 7.34 8.08 9.79 10.94 10.935
EV/FCF -13.89 -62.40 24.03 -29.34 -46.83 -18.56 -43.01 16.17 18.03 14.99 10.50 11.69 16.39 103.29 -100.15 -53.15 -53.53 21.61 24.36 29.45 29.450
Earnings Yield 4.4% 5.5% 5.3% 6.5% 5.9% 6.6% 8.4% 10.7% 10.2% 8.4% 7.0% 3.1% 5.3% 4.3% 5.7% 6.1% 9.9% 8.9% 7.5% 7.0% 7.03%
FCF Yield -7.8% -1.7% 4.7% -4.2% -2.5% -6.6% -2.8% 7.1% 6.6% 7.3% 10.3% 9.4% 6.5% 1.0% -1.1% -2.0% -1.9% 4.7% 4.3% 3.5% 3.55%
PEG Ratio snapshot only 0.287
Price/Tangible Book snapshot only 4.805
EV/OCF snapshot only 28.027
EV/Gross Profit snapshot only 8.341
Acquirers Multiple snapshot only 15.624
Shareholder Yield snapshot only 1.79%
Graham Number snapshot only $36.48
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 4.19 4.37 3.64 2.74 2.73 2.69 3.07 3.20 3.79 3.66 3.45 2.84 3.41 2.58 2.73 3.23 3.73 4.03 3.67 4.10 4.101
Quick Ratio 2.75 2.81 2.10 1.63 1.39 1.39 1.58 1.53 1.83 2.16 2.08 1.66 1.94 1.44 1.45 1.71 2.14 2.25 2.14 2.45 2.449
Debt/Equity 0.69 0.65 0.65 0.63 0.62 0.59 0.55 0.47 0.43 0.42 0.42 0.44 0.47 0.56 0.56 0.45 0.33 0.28 0.45 0.38 0.380
Net Debt/Equity 0.38 0.36 0.38 0.56 0.47 0.53 0.42 0.34 0.34 0.20 0.17 0.22 0.22 0.41 0.27 0.26 0.08 0.07 0.20 0.18 0.184
Debt/Assets 0.35 0.34 0.33 0.33 0.32 0.31 0.30 0.29 0.27 0.26 0.26 0.26 0.27 0.29 0.30 0.27 0.21 0.19 0.27 0.24 0.243
Debt/EBITDA 2.24 1.95 2.64 2.70 2.60 2.50 2.01 2.09 2.64 2.93 3.40 3.11 1.70 1.68 1.52 1.17 0.81 0.68 1.03 0.91 0.907
Net Debt/EBITDA 1.23 1.07 1.56 2.43 1.98 2.24 1.55 1.51 2.07 1.39 1.37 1.54 0.79 1.23 0.75 0.67 0.19 0.17 0.47 0.44 0.439
Interest Coverage 14.04 14.46 10.02 11.14 10.77 10.47 12.37 11.70 7.68 6.53 4.92 5.71 12.73 14.60 16.84 15.55 18.06 19.80 22.56 22.86 22.858
Equity Multiplier 1.96 1.91 1.97 1.93 1.96 1.94 1.82 1.64 1.59 1.62 1.63 1.70 1.76 1.90 1.82 1.67 1.55 1.50 1.66 1.56 1.564
Cash Ratio snapshot only 0.720
Debt Service Coverage snapshot only 24.575
Cash to Debt snapshot only 0.516
FCF to Debt snapshot only 0.381
Defensive Interval snapshot only 983.0 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 1.09 1.03 0.90 0.86 0.96 0.99 1.06 0.91 0.96 0.97 1.01 1.03 1.09 1.09 1.12 1.17 1.18 1.18 1.07 1.14 1.143
Inventory Turnover 3.01 2.93 2.58 2.28 2.48 2.65 2.61 2.31 2.10 2.30 2.43 2.50 2.48 2.46 2.34 2.51 2.65 2.50 2.35 2.44 2.437
Receivables Turnover 4.86 6.14 3.77 2.73 4.08 4.21 4.99 3.64 4.25 3.80 4.29 4.52 4.64 3.86 4.52 4.39 4.43 3.97 4.22 4.12 4.121
Payables Turnover 12.02 11.28 8.60 7.69 10.12 11.40 10.67 11.07 10.65 11.04 10.96 11.60 11.35 9.93 9.37 10.32 12.01 10.55 9.62 11.99 11.990
DSO 75 59 97 134 89 87 73 100 86 96 85 81 79 95 81 83 82 92 86 89 88.6 days
DIO 121 125 142 160 147 138 140 158 174 159 150 146 147 148 156 145 138 146 155 150 149.8 days
DPO 30 32 42 47 36 32 34 33 34 33 33 31 32 37 39 35 30 35 38 30 30.4 days
Cash Conversion Cycle 166 152 196 246 200 192 179 225 226 222 202 195 194 206 198 193 190 203 203 208 207.9 days
Fixed Asset Turnover snapshot only 128.814
Operating Cycle snapshot only 238.4 days
Cash Velocity snapshot only 8.301
Capital Intensity snapshot only 0.961
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 9.0% 13.3% -2.2% 10.5% 9.4% 7.0% 23.7% 9.6% 8.8% 9.0% 2.9% 16.8% 21.0% 26.4% 29.7% 23.7% 23.7% 18.2% 16.4% 16.4% 16.45%
Net Income -32.3% -9.8% -46.2% -13.3% -9.0% -21.0% 50.6% 91.3% 47.0% 38.9% -12.7% -71.2% -8.4% 27.1% 1.2% 3.2% 1.1% 68.0% 28.1% 52.2% 52.19%
EPS -28.7% -3.9% -43.1% -12.9% -6.9% -18.5% 55.9% 97.8% 53.2% 40.4% -10.2% -70.0% -1.3% 37.6% 1.3% 3.4% 1.1% 69.7% 30.8% 53.7% 53.72%
FCF -4.0% 57.2% 1.4% 75.8% 78.3% -1.5% -1.6% 3.0% 3.2% 2.2% 4.9% 30.0% 74.6% -64.8% -1.3% -1.5% -1.3% 2.7% 5.0% 3.4% 3.35%
EBITDA -25.0% -3.5% -37.3% -11.5% -11.5% -21.3% 28.5% 20.1% -13.4% -20.9% -45.2% -38.6% 68.9% 1.3% 2.4% 2.2% 1.0% 63.9% 52.2% 41.3% 41.26%
Op. Income -39.7% -10.1% -26.2% 13.2% 10.8% -20.2% 17.7% 12.5% 39.7% 46.5% 20.6% 24.5% 25.7% 63.4% 81.8% 49.0% 29.1% 10.5% -7.6% 21.5% 21.54%
OCF Growth snapshot only 5.31%
Asset Growth snapshot only 21.76%
Equity Growth snapshot only 30.03%
Debt Growth snapshot only 9.18%
Shares Change snapshot only -1.00%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 17.6% 18.2% 13.7% 15.7% 16.2% 15.0% 16.1% 9.8% 9.1% 9.8% 7.6% 12.3% 12.9% 13.9% 18.2% 16.6% 17.6% 17.7% 15.8% 18.9% 18.94%
Revenue 5Y 12.9% 14.9% 12.1% 13.6% 14.4% 14.0% 17.1% 15.5% 14.2% 14.0% 13.4% 14.7% 15.6% 16.0% 15.9% 13.8% 14.2% 14.6% 13.4% 15.3% 15.32%
EPS 3Y 28.1% 19.7% 3.1% 1.4% 3.3% 2.2% 7.2% 11.1% 0.5% 3.2% -7.3% -19.8% 12.0% 16.3% 47.1% 37.4% 47.4% 48.6% 38.8% 26.3% 26.31%
EPS 5Y 30.2% 5.4% -4.7% -3.8% -4.2% 12.3% 22.8% 40.8% 24.5% 14.4% 8.9% -9.2% 10.7% 15.6% 20.3% 12.4% 16.3% 20.8% 18.8% 28.3% 28.26%
Net Income 3Y 22.0% 15.1% -1.2% -2.4% -0.3% -1.3% 3.8% 6.5% -3.2% -0.3% -10.9% -21.8% 7.0% 11.7% 41.5% 32.5% 42.5% 43.7% 34.1% 22.8% 22.80%
Net Income 5Y 28.1% 3.7% -6.2% -5.4% -6.5% 8.2% 18.1% 35.4% 19.4% 10.8% 4.9% -12.5% 5.9% 11.2% 16.0% 8.0% 12.3% 16.2% 14.3% 25.2% 25.15%
EBITDA 3Y 11.0% 11.1% -0.6% 2.5% 3.3% -0.1% 1.5% -6.5% -16.9% -15.6% -23.8% -13.3% 9.0% 12.7% 33.3% 33.7% 43.0% 43.9% 41.0% 41.2% 41.20%
EBITDA 5Y 27.4% 33.7% 14.3% 11.5% 8.3% 6.6% 14.2% 11.8% 0.9% -3.1% -7.1% -4.5% 10.0% 12.6% 14.0% 10.2% 14.2% 17.8% 17.7% 24.5% 24.50%
Gross Profit 3Y 15.4% 15.3% 10.0% 10.3% 8.8% 4.4% 4.0% -1.0% -0.9% 0.1% -2.1% 2.3% 5.8% 8.5% 16.2% 14.1% 15.9% 19.7% 17.3% 24.0% 24.04%
Gross Profit 5Y 17.8% 20.2% 13.4% 12.2% 10.7% 8.1% 11.2% 9.9% 8.8% 7.9% 7.5% 8.3% 10.3% 11.9% 12.0% 8.2% 7.4% 8.5% 7.1% 12.4% 12.38%
Op. Income 3Y 9.8% 9.6% 1.4% 0.8% -0.0% -6.4% -4.1% -6.6% -2.3% 1.7% 1.6% 16.6% 24.8% 24.1% 37.2% 27.8% 31.4% 38.3% 26.5% 31.1% 31.13%
Op. Income 5Y 35.6% 46.0% 16.5% 13.4% 7.6% 4.9% 14.9% 19.4% 15.4% 9.0% 8.1% 7.5% 11.9% 14.4% 14.1% 8.6% 8.6% 13.7% 12.0% 23.5% 23.48%
FCF 3Y — — -3.2% — — — — 4.0% 12.8% — — — — — — — — — — 11.8% 11.85%
FCF 5Y — — 2.2% — — — — 17.9% 20.8% 12.7% 14.7% 27.1% 19.7% -12.5% — — — — — — —
OCF 3Y -17.5% -31.8% 5.5% — — — — 5.8% 15.5% 19.7% — — 72.0% 39.0% — — — — — 7.3% 7.34%
OCF 5Y 2.2% -7.4% 8.5% — — — — 13.6% 12.5% 12.4% 11.9% 18.3% 16.4% -8.3% — — — 13.2% — — —
Assets 3Y 18.4% 20.6% 19.6% 24.4% 19.7% 18.3% 18.5% 18.5% 17.2% 10.3% 6.1% 2.2% 9.1% 12.8% 13.6% 7.6% 10.3% 9.4% 16.9% 12.9% 12.87%
Assets 5Y 28.5% 22.9% 23.3% 24.6% 21.4% 20.4% 19.2% 21.1% 14.5% 16.4% 14.5% 15.5% 14.2% 16.0% 17.9% 14.5% 15.9% 10.2% 12.1% 8.7% 8.70%
Equity 3Y 6.4% 9.0% 8.1% 14.4% 11.9% 11.0% 14.6% 18.3% 15.9% 13.3% 14.9% 6.7% 13.0% 13.1% 16.6% 12.9% 19.4% 19.4% 20.5% 14.7% 14.67%
Book Value 3Y 11.8% 13.4% 12.7% 18.8% 15.9% 15.0% 18.5% 23.5% 20.4% 17.4% 19.5% 9.4% 18.3% 17.7% 21.2% 17.1% 23.5% 23.4% 24.7% 18.0% 17.95%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.89 0.94 0.91 0.97 0.97 0.98 0.95 0.98 0.98 0.98 0.94 0.99 0.98 0.95 0.93 0.91 0.89 0.91 0.89 0.94 0.938
Earnings Stability 0.30 0.47 0.07 0.02 0.00 0.43 0.34 0.50 0.31 0.34 0.03 0.04 0.05 0.40 0.27 0.05 0.35 0.55 0.56 0.51 0.511
Margin Stability 0.88 0.89 0.92 0.93 0.91 0.88 0.87 0.88 0.87 0.85 0.85 0.86 0.89 0.87 0.87 0.86 0.86 0.86 0.86 0.88 0.884
Rev. Growth Consistency 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 0 0 0
Earnings Persistence 0.87 0.96 0.82 0.95 0.96 0.92 0.50 0.50 0.81 0.84 0.95 0.50 0.97 0.89 0.50 0.50 0.50 0.50 0.89 0.50 0.500
Earnings Smoothness 0.62 0.90 0.40 0.86 0.91 0.77 0.60 0.37 0.62 0.67 0.86 0.00 0.91 0.76 0.27 0.00 0.27 0.49 0.75 0.59 0.586
ROE Trend -0.07 -0.01 -0.13 -0.10 -0.10 -0.08 -0.03 0.07 0.00 -0.02 -0.03 -0.12 -0.00 0.05 0.10 0.09 0.09 0.08 0.06 0.13 0.130
Gross Margin Trend -0.03 -0.02 -0.04 -0.05 -0.07 -0.09 -0.08 -0.06 -0.03 -0.03 -0.02 -0.02 -0.01 0.02 0.04 0.02 -0.00 -0.01 -0.02 0.03 0.032
FCF Margin Trend -0.27 -0.04 0.14 0.01 0.02 -0.02 0.02 0.27 0.19 0.16 0.11 0.10 0.09 0.02 -0.08 -0.16 -0.13 0.02 0.04 0.05 0.051
Sustainable Growth Rate 20.5% 22.1% 15.5% 15.2% 16.9% 16.4% 20.7% 25.9% 20.5% 18.9% 15.3% 6.8% 16.8% 21.2% 28.3% 26.6% 30.9% 30.9% 29.8% 32.4% 32.43%
Internal Growth Rate 13.2% 13.7% 8.3% 8.5% 9.4% 9.3% 12.3% 17.1% 13.2% 12.0% 9.8% 4.3% 11.1% 13.7% 19.5% 18.8% 23.3% 22.7% 20.8% 25.2% 25.21%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.36 0.22 1.56 -0.22 -0.17 -0.67 -0.09 0.79 0.85 1.12 1.77 3.62 1.48 0.42 -0.05 -0.19 -0.11 0.57 0.61 0.53 0.530
FCF/OCF -5.01 -1.45 0.57 2.97 2.51 1.49 3.68 0.84 0.76 0.78 0.83 0.83 0.83 0.58 3.58 1.74 1.73 0.93 0.95 0.95 0.952
FCF/Net Income snapshot only 0.504
OCF/EBITDA snapshot only 0.363
CapEx/Revenue 23.0% 6.3% 5.7% 4.0% 2.3% 2.9% 2.5% 2.0% 2.5% 2.7% 2.6% 2.4% 2.3% 2.0% 2.0% 1.9% 1.3% 0.6% 0.5% 0.5% 0.45%
CapEx/Depreciation snapshot only 0.251
Accruals Ratio 0.08 0.09 -0.04 0.10 0.10 0.14 0.12 0.03 0.02 -0.01 -0.07 -0.11 -0.05 0.07 0.17 0.19 0.21 0.08 0.07 0.09 0.095
Sloan Accruals snapshot only 0.091
Cash Flow Adequacy snapshot only 20.691
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — 0.0% — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.3% 1.3% 83.3% 41.6% 48.2% 59.7% 38.1% 43.7% 91.1% 80.8% 1.3% 2.7% 1.1% 1.0% 55.3% 39.0% 10.7% 19.5% 24.0% 25.5% 25.46%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.1% 1.7% 1.8% 1.8% 1.79%
Net Buyback Yield 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.0% 1.7% 1.7% 1.7% 1.75%
Total Shareholder Return 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.0% 1.7% 1.7% 1.7% 1.75%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.61 0.76 0.78 0.82 0.84 0.83 0.83 0.76 0.75 0.75 0.74 0.81 0.77 0.77 0.76 0.74 0.75 0.74 0.75 0.76 0.758
Interest Burden (EBT/EBIT) 1.19 0.95 0.90 0.91 0.91 0.90 0.97 1.56 1.85 1.98 2.16 0.82 0.92 0.93 0.98 0.94 0.94 0.95 0.93 0.97 0.971
EBIT Margin 0.15 0.16 0.12 0.12 0.12 0.11 0.13 0.14 0.09 0.07 0.06 0.06 0.13 0.15 0.20 0.19 0.23 0.22 0.23 0.24 0.239
Asset Turnover 1.09 1.03 0.90 0.86 0.96 0.99 1.06 0.91 0.96 0.97 1.01 1.03 1.09 1.09 1.12 1.17 1.18 1.18 1.07 1.14 1.143
Equity Multiplier 1.75 1.84 2.02 1.93 1.96 1.93 1.89 1.77 1.75 1.76 1.72 1.67 1.67 1.76 1.73 1.68 1.64 1.67 1.73 1.61 1.610
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $1.12 $1.28 $0.88 $1.03 $1.05 $1.05 $1.37 $2.04 $1.60 $1.47 $1.23 $0.61 $1.58 $2.02 $2.81 $2.68 $3.35 $3.43 $3.67 $4.12 $4.12
Book Value/Share $5.66 $5.84 $5.94 $6.82 $6.61 $6.70 $7.13 $8.75 $8.80 $8.80 $8.78 $8.89 $9.38 $9.54 $10.57 $10.93 $12.43 $12.60 $13.82 $14.36 $14.77
Tangible Book/Share $5.61 $5.80 $5.90 $6.78 $6.58 $6.67 $7.11 $8.73 $8.77 $8.78 $8.76 $8.87 $9.36 $9.52 $10.56 $10.93 $12.43 $12.60 $11.61 $12.19 $12.19
Revenue/Share $10.44 $10.97 $10.37 $11.27 $11.68 $12.12 $13.27 $12.77 $13.23 $13.36 $14.03 $15.50 $17.25 $18.28 $19.21 $19.88 $21.03 $21.82 $22.83 $23.38 $24.04
FCF/Share $-2.00 $-0.41 $0.78 $-0.67 $-0.45 $-1.05 $-0.45 $1.36 $1.03 $1.29 $1.82 $1.84 $1.95 $0.49 $-0.52 $-0.87 $-0.65 $1.82 $2.13 $2.08 $2.14
OCF/Share $0.40 $0.28 $1.38 $-0.23 $-0.18 $-0.70 $-0.12 $1.62 $1.37 $1.65 $2.18 $2.22 $2.34 $0.85 $-0.15 $-0.50 $-0.38 $1.96 $2.25 $2.18 $2.24
Cash/Share $1.77 $1.72 $1.57 $0.43 $0.98 $0.42 $0.89 $1.13 $0.82 $1.96 $2.21 $1.97 $2.38 $1.42 $2.96 $2.14 $3.16 $2.67 $3.36 $2.82 $2.90
EBITDA/Share $1.75 $1.96 $1.45 $1.58 $1.58 $1.59 $1.93 $1.96 $1.43 $1.28 $1.09 $1.25 $2.59 $3.18 $3.87 $4.22 $5.12 $5.26 $6.00 $6.02 $6.02
Debt/Share $3.92 $3.82 $3.83 $4.28 $4.11 $3.98 $3.89 $4.10 $3.77 $3.73 $3.70 $3.90 $4.42 $5.33 $5.87 $4.95 $4.13 $3.58 $6.17 $5.46 $5.46
Net Debt/Share $2.15 $2.10 $2.26 $3.85 $3.13 $3.57 $3.00 $2.97 $2.95 $1.77 $1.49 $1.93 $2.04 $3.91 $2.91 $2.81 $0.97 $0.91 $2.81 $2.64 $2.64
Per Employee
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Employee Count snapshot only 206
Revenue/Employee snapshot only $376436.89
Income/Employee snapshot only $66320.39
EBITDA/Employee snapshot only $96868.93
FCF/Employee snapshot only $33456.31
Assets/Employee snapshot only $361694.17
Market Cap/Employee snapshot only $942786.88
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 7.742
Altman Z-Prime snapshot only 14.891
Piotroski F-Score 3 5 5 3 4 4 5 8 8 8 6 6 7 6 5 5 5 8 7 8 8
Beneish M-Score -1.64 -1.47 -2.95 -1.83 -1.72 -1.27 -1.61 -2.47 -2.08 -2.61 -2.72 -2.70 -2.74 -1.61 0.60 -0.25 -1.33 -1.07 -1.85 -2.06 -2.059
Ohlson O-Score snapshot only -8.312
ROIC (Greenblatt) snapshot only 45.42%
Net-Net WC snapshot only $7.95
EVA snapshot only $4213059.03
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AAA
Credit Score 76.21 78.49 79.18 73.10 72.45 73.40 77.28 86.64 82.59 82.73 78.03 80.38 88.09 83.11 80.83 82.31 84.65 91.76 92.66 95.71 95.709
Credit Grade snapshot only 1
Credit Trend snapshot only 13.397
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 90
Sector Credit Rank snapshot only 93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms